Press Releases
Nomination committee appointed for Cyxone Annual General Meeting 2023
8 Nov, 2022 13:35 CETInterim Report 1 January to 30 September 2022
27 Oct, 2022 08:30 CESTRegulatoryCyxone presents T20K program at the ECTRIMS conference
26 Oct, 2022 10:57 CESTCyxone receive regulatory approval to start clinical Phase 2b study in RA
19 Sep, 2022 08:30 CESTCyxone appoints Erika Samuelsson as Chief Development Officer
2 Sep, 2022 11:01 CEST